Patents for A61P 17 - Drugs for dermatological disorders (106,455)
07/2001
07/26/2001WO2001052857A1 Drospirenone for hormone replacement therapy
07/26/2001WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
07/26/2001WO2001052847A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
07/26/2001WO2001052845A1 Gyrase inhibitors and uses thereof
07/26/2001WO2001052842A1 Compositions for the prevention of diaper dermatitis
07/26/2001WO2001052840A1 Use of isoflavones and/or african plum extracts for preparing a composition designed to inhibit 5$g(a)-reductase activity, in pharmacology particularly in dermatology, in cosmetics and as food additive
07/26/2001WO2001052837A2 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
07/26/2001WO2001052809A1 Cosmetic and/or pharmaceutical preparations containing an active quantity of an arrabidaea chica extract
07/26/2001WO2001052808A1 Treatment of uv induced immunosuppression
07/26/2001WO2001046180A8 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
07/26/2001WO2001014886A3 Inhibitors of binding between proteins and macromolecular ligands
07/26/2001WO2001014415A3 Egfh2 genes and gene products
07/26/2001WO2001001748A3 Peptide compounds that bind her2
07/26/2001WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins
07/26/2001US20010009917 Reducing associated adverse effects; 5-lipoxygenase inhibitor, useful in treatment of conditions related to elevated leukotriene levels
07/26/2001US20010009909 Of fatty acid ester, such as sorbitan monolaurate or monostearate, in aqueous medium containing an anionic detergent surfactant; reducing eye-irritant and improving thickening for better distribution and emulsification; shampoo
07/26/2001US20010009662 AB block polymers, comprising a polylactone part made from monomers such as lactic acid, and B is derived from hydroxyl, amine, or carboxyl terminated compound endcapped with nonreactive group; storage stablity; anti-adhesions
07/26/2001DE10037590A1 Natural plant disinfectant and its preparation
07/26/2001DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders
07/26/2001CA2398695A1 Chondromodulin-i related peptide
07/26/2001CA2398086A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
07/26/2001CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production
07/26/2001CA2397833A1 Novel haptotactic peptides
07/26/2001CA2397830A1 Compositions for the prevention of diaper dermatitis
07/26/2001CA2397774A1 Jak/stat pathway inhibitors and the uses thereof
07/26/2001CA2397686A1 Gyrase inhibitors and uses thereof
07/26/2001CA2397665A1 Alpha v integrin receptor antagonists
07/26/2001CA2397633A1 Corticotropin releasing factor antagonists
07/26/2001CA2397627A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
07/26/2001CA2396995A1 Treatment of uv induced immunosuppression
07/26/2001CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides
07/26/2001CA2395054A1 Human polynucleotides, polypeptides, and antibodies
07/26/2001CA2394612A1 Antimicrobial compositions
07/25/2001EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides
07/25/2001EP1117785A1 Human kinesin-like motor protein
07/25/2001EP1117772A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
07/25/2001EP1117764A1 Primate embryonic stem cells with compatible histocompatibility genes
07/25/2001EP1117695A1 Biocompatible polymers, preparation method and compositions containing same
07/25/2001EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use
07/25/2001EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders
07/25/2001EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
07/25/2001EP1117653A1 Chemical compounds
07/25/2001EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
07/25/2001EP1117641A1 Indolin derivatives as sun protection agents
07/25/2001EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
07/25/2001EP1117635A1 2-substituted ketoamides
07/25/2001EP1117628A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
07/25/2001EP1117438A1 Tie2 antagonist antibodies
07/25/2001EP1117414A1 Reduction of oxidative stress factors
07/25/2001EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001EP1117373A1 Hair tonic
07/25/2001EP1117372A2 Method of treating hair loss using sulfonamides
07/25/2001EP1117371A2 Method of treating hair loss using ketoamides
07/25/2001EP1117296A1 Combination of bisphosphonate and tetracycline
07/25/2001EP0772610B9 Dihydrobenzofuranes
07/25/2001CN1305481A Piperazino derivatives as neurokinin antafonists
07/25/2001CN1305480A Pyrolo [2,3-d] pyrimidine compounds
07/25/2001CN1305479A Pyrrolo [2,3-d] pyrmidine compounds
07/25/2001CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction
07/25/2001CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein
07/25/2001CN1305465A Aryl alkanoylpyridazines
07/25/2001CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders
07/25/2001CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
07/25/2001CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase
07/25/2001CN1305385A Method and compositions using terfenadine metabolites in combination with leukotriene inhibitors
07/25/2001CN1304766A Plant day cream for treating cystis and nodular acne
07/25/2001CN1304764A Plant night cream for treating pustular acne
07/25/2001CN1304763A Medicine for treating scleroderma and its preparing process
07/25/2001CN1304762A Medicine for treating burn and scald
07/25/2001CN1304761A Regenerating medicine for skin injury and its preparing process
07/25/2001CN1304759A Dermatitis ointment and its preparing process
07/25/2001CN1304756A Chinese medicine for treating dermatopathy and its preparing process
07/25/2001CN1304749A Chinese-medicinal composition for treating acne, removing spots and beautifying and whitening face
07/25/2001CN1304743A Medicine for treating injury
07/25/2001CN1304737A Medicine 'Baicaogen' for treating burn
07/25/2001CN1304734A Liniment for treating dermatopathy
07/25/2001CN1304731A Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer
07/25/2001CN1304714A Health-care shampoo and its preparing process
07/25/2001CN1304699A Skin-building face-beautifying beverage
07/25/2001CN1068879C Dihydrobenzofuranes
07/25/2001CN1068785C Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer
07/25/2001CN1068783C Ointment for anti-inflammatory and curing burn and preparation method thereof
07/25/2001CN1068781C Chinese medicine of spraying-applying dual puropose mailnly for treating burn and scald preparation method thereof
07/25/2001CN1068776C Cosmetic face cleaning powder
07/24/2001US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
07/24/2001US6265564 Expressed ligand-vascular intercellular signalling molecule
07/24/2001US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders
07/24/2001US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers
07/24/2001US6265446 Antiinflammatory agents; autoimmune diseases
07/24/2001US6265434 Antiinflammatory agents
07/24/2001US6265433 LTA4 hydrolase inhibitors
07/24/2001US6265425 Side effect reduction; retinoic acid metabolism blocking agent
07/24/2001US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/24/2001US6265403 Angiogenesis inhibitors
07/24/2001US6265386 In a patient undergoing treatment with an aminoglycoside antibiotic
07/24/2001US6265218 Introducing promoter and heterologous dna encoding a product into plasmid containing antibiotic resistance selection marker, amplifying, using restriction enzymes to form two fragments, cyclizing to form separate plasmids
07/24/2001US6265184 Polynucleotides encoding chemokine receptor 88C
07/24/2001US6264966 Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
07/24/2001US6264965 Composition in the form of an O/W emulsion with a high wax content and uses thereof in cosmetics and dermatology